Protagonist Therapeutics, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Protagonist Therapeutics, Inc has filed 682 SEC EDGAR filings since 28 Sep 2006

SEC filing history

Showing 176-200 of 681 matching filings.

Per page
25
Current page
8
PRE 14A File 001-37852

FORM-PRE14A

Filing date
12 Apr 2024
Reporting date
20 Jun 2024
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37852

144 filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Mar 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37852

144 filing

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37852

144 filing

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37852

144 filing

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37852

144 filing

Filing date
29 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277409

FORM S-8

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

PROTAGONIST THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

PROTAGONIST THERAPEUTICS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

PROTAGONIST THERAPEUTICS, INC.

Filing date
07 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SC 13G/A filing

Filing date
02 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .